(NP -LCB-/-LRB- Cortisone-resistant/JJ bronchial/JJ asthma/NN -RCB-/-RRB-)
(S (S (NP-SBJ There/EX) (VP is/VBZ (NP-PRD (NP general/JJ agreement/NN) (PP on/IN (NP (NP the/DT inflammatory/JJ pathogenesis/NN) (PP of/IN (NP bronchial/JJ asthma/NN)))))) :/:) (S (NP-SBJ-COOD-50 (NP (NP an/DT accumulation/NN) (PP of/IN (NP-104 activated/VBN eosinophils/NNS))) ,/, (NP (NP=104 degranulated/VBN mast/NN cells/NNS)) ,/, (NP (NP=104 T/NN lymphocytes/NNS)) and/CC (NP (PP in/IN (NP (ADJP very/RB severe/JJ) forms/NNS)) ,/, (NP=104 granulocytes/NNS))) (VP has/VBZ (ADVP-TMP constantly/RB) (VP been/VBN (VP found/VBN (NP *-50/-NONE-) (PP in/IN (NP the/DT bronchial/JJ mucosa/NN))))) ./.))
(S (PP In/IN (NP allergic/JJ bronchial/JJ asthma/NN)) ,/, (NP-SBJ-51 inflammation/NN) (VP seems/VBZ (S (NP-SBJ-52 *-51/-NONE-) (VP to/TO (VP be/VB (VP orchestrated/VBN (NP *-52/-NONE-) (PP (ADVP predominantly/RB) by/IN (NP-LGS (NP a/DT subset/NN) (PP of/IN (NP T/NN lymphocytes/NNS)) ,/, (PP with/IN (NP (NP a/DT phenotype/NN) (ADJP similar/JJ (PP to/TO (NP (NP the/DT Th2/NN subset/NN) (ADJP able/JJ (S (NP-SBJ */-NONE-) (VP to/TO (VP produce/VB (NP-COOD (NP IL-4/NN) and/CC (NP IL-5/NN)))))))))))))))))) ./.)
(S (SBAR Although/IN (S (NP-SBJ corticosteroids/NNS) (VP are/VBP (NP-PRD (NP the/DT (ADJP most/RBS potent/JJ) therapeutic/JJ agents/NNS) (VP used/VBN (NP */-NONE-) (PP for/IN (NP this/DT disease/NN))))))) ,/, (NP-SBJ their/PRP$ anti-inflammatory/JJ effect/NN) (VP differs/VBZ (PP-COOD (PP from/IN (NP patient/NN)) (PP to/TO (NP patient/NN)))) ./.)
(S (NP-SBJ-53 (NP Some/DT criteria/NNS) (SBAR (WHNP-54 which/WDT) (S (NP-SBJ-55 *T*-54/-NONE-) (VP can/MD (VP be/VB (VP used/VBN (NP-56 *-55/-NONE-) (S (NP-SBJ *-56/-NONE-) (VP to/TO (VP define/VB (NP steroid-resistant/JJ bronchial/JJ asthma/NN)))))))))) (VP are/VBP (VP listed/VBN (NP *-53/-NONE-) (ADVP here/RB))) ./.)
(S (NP-SBJ This/DT review/NN) (VP analyzes/VBZ (NP (NP various/JJ molecular/JJ alterations/NNS) (ADJP responsible/JJ (PP for/IN (NP (NP the/DT deficient/JJ response/NN) (PP to/TO (NP corticosteroid/NN treatment/NN)) (VP observed/VBN (NP */-NONE-) (PP in/IN (NP (ADJP steroid-resistant/JJ bronchial/JJ asthmatic/JJ) subjects/NNS)))))))) ./.)
(S (NP-SBJ (NP New/JJ knowledge/NN) (PP on/IN (NP (NP the/DT mechanism/NN) (PP of/IN (NP steroid/NN resistance/NN))))) (VP may/MD (VP have/VB (NP (NP important/JJ implications/NNS) (PP for/IN (NP (NP the/DT treatment/NN) (PP of/IN (NP-COOD (NP chronic/JJ asthma/NN) and/CC (NP other/JJ diseases/NNS)))))))) ./.)
